Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD79a Mouse anti-Human, PE, Clone: HM57, BD

Mouse Monoclonal Antibody

Manufacturer:  BD Biosciences 563777

Catalog No. BDB563777


Add to cart

Description

Description

The HM57 monoclonal antibody specifically binds to the cytoplasmic domain of CD79a. CD79a is a 47-kDa type 1 transmembrane glycoprotein present on B lymphocytes. CD79a is also referred to as mb-1, IGA and Ig-alpha (Ig- α ). It is expressed on B cells at various stages of differentiation, from the pre-B cell stage, probably befo re expression of cytoplasmic λ chain, to the plasma cell stage, in which it is detected only in the cytoplasm. CD79a associates with CD79b to form part of the B-cell receptor complex. It has been suggested that CD79a may play a role in mediating the transport of IgM to the cell surface. This antibody reportedly may crossreact with monkey, mouse, rat, bovine, canine, chicken, equine, guinea pig, porcine, and rabbit CD79a.

Specifications

Specifications

CD79a
HM57
CD79A; CD79α; Immunoglobulin-associated alpha; Ig-alpha; IGA; Igα; MB-1
Affinity Purified
Human CD79a Peptide
100 Tests
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Monoclonal
Flow Cytometry
PE
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Murine
IgG1, κ
RUO
Primary
Bovine, Canine, Chicken, Equine, Guinea Pig, Hamster, Human, Murine, Porcine, Rabbit, Rat
SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit